ROCKVILLE, Md., Sept. 3, 2013 /PRNewswire/ -- Synthetic
Biologics, Inc. (NYSE-MKT: SYN), a developer of biologics focused
on the prevention and treatment of serious infectious
diseases, announced today that Jeffrey
Riley, CEO, will present at the 15th Annual
Rodman & Renshaw Global Investment Conference, sponsored by
H.C. Wainwright & Co.,
LLC. Mr. Riley is scheduled to present at 12:05 p.m. (Eastern Time) on Monday, September 9, 2013 at the Millennium
Broadway Hotel in New York
City.
A live webcast of Synthetic Biologics' presentation can be
accessed by logging onto the internet at
http://wsw.com/webcast/rrshq23/SYN. After the presentation, a
replay will be archived and accessible for 30 days at the same
website.
Mr. Riley, as well as Synthetic Biologics' CFO, C. Evan Ballantyne, will be available to
participate in one-on-one meetings with attendees who are
registered for the conference. If you are an institutional
investor, and would like to attend the Company's presentation,
please register for the Rodman & Renshaw conference using the
following link www.rodm.com. Once your registration is confirmed,
you will be prompted to log into the conference website and may
request a one-on-one meeting with the Company.
About Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (NYSE-MKT: SYN) is a biotechnology
company focused on the development of biologics for the prevention
and treatment of serious infectious diseases. The Company is
developing an oral enzyme for the prevention of C. difficile
infections, and a series of monoclonal antibody therapies for the
treatment of Pertussis and Acinetobacter infections. In
addition, the Company is developing a drug candidate for the
treatment of relapsing-remitting multiple sclerosis and cognitive
dysfunction in multiple sclerosis. For more information, please
visit Synthetic Biologics' website at
www.syntheticbiologics.com.
To download Synthetic Biologics' investor relations mobile
device app, which allows users access to the Company's SEC
documents, press releases and events, please click on the following
links to download the IRapp on your iPhone and iPad or your Android
mobile device.
SOURCE Synthetic Biologics, Inc.